ArticleScientific reports2025
The clinical implications of the interaction between hypothyroidism and diabetes mellitus.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
This study aims to investigate the prevalence of hypothyroidism in T2DM patients and its relationship with lipid profiles and clinical parameters. The results indicate that 82% of the T2DM patients did not have hypothyroidism, whereas 18% had hypothyroidism. People with both conditions had a higher average body mass index (BMI) of 32.1 ± 6.1 kg/m² than those with only T2DM did (mean: 34.4 ± 6.8 kg/m², p < 0.001). Compared with the control group, the hypothyroid group presented higher glycosylated hemoglobin (HbA1c) levels (mean: 10.1% vs. 5.48%, p < 0.001). Compared with T2DM patients without hypothyroidism, T2DM patients with hypothyroidism presented significantly poorer lipid profiles, with lower high-density lipoprotein and higher low-density lipoprotein and triglyceride. T2DM patients with hypothyroidism had a greater prevalence of vitamin D deficiency (average: 28.2 ± 20.0 ng/mL) than control patients did (average: 59.5 ± 11.7 ng/mL, p < 0.001). In conclusion, T2DM with hypothyroidism is associated with poorer metabolic indicators than those of T2DM patients without hypothyroidism. Individuals who have both conditions have an increased BMI, higher FBS levels, poorer lipid profiles, and decreased vitamin D levels. These results highlight the importance of implementing specific management plans for T2DM patients who also have hypothyroidism.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.